Cargando…
Development of a novel, sensitive translational immunoassay to detect plasma glial fibrillary acidic protein (GFAP) after murine traumatic brain injury
BACKGROUND: Glial fibrillary acidic protein (GFAP) has emerged as a promising fluid biomarker for several neurological indications including traumatic brain injury (TBI), a leading cause of death and disability worldwide. In humans, serum or plasma GFAP levels can predict brain abnormalities includi...
Autores principales: | Button, Emily B., Cheng, Wai Hang, Barron, Carlos, Cheung, Honor, Bashir, Asma, Cooper, Jennifer, Gill, Jasmine, Stukas, Sophie, Baron, David C., Robert, Jerome, Rowe, Elyn M., Cripton, Peter A., Wellington, Cheryl L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7938597/ https://www.ncbi.nlm.nih.gov/pubmed/33678186 http://dx.doi.org/10.1186/s13195-021-00793-9 |
Ejemplares similares
-
Blood Levels of Glial Fibrillary Acidic Protein (GFAP) in Patients with Neurological Diseases
por: Mayer, Christoph A., et al.
Publicado: (2013) -
Glial Fibrillary Acidic Protein (GFAP): Neuroinflammation Biomarker in Acute Ischemic Stroke
por: Amalia, Lisda
Publicado: (2021) -
A case of glial fibrillary acidotic protein (GFAP) meningoencephalitis with rheumatoid arthritis
por: Salari, Mehri, et al.
Publicado: (2023) -
CHIMERA repetitive mild traumatic brain injury induces chronic behavioural and neuropathological phenotypes in wild-type and APP/PS1 mice
por: Cheng, Wai Hang, et al.
Publicado: (2019) -
Radiographic evolution of myelitis in a case of glial fibrillary acidic protein (GFAP) astrocytopathy
por: Goyne, Christopher E, et al.
Publicado: (2023)